WDR24

gene
On this page

Also known as DKFZp434F054JFP7

Summary

WDR24 (WD repeat domain 24, HGNC:20852) is a protein-coding gene on chromosome 16p13.3, encoding GATOR2 complex protein WDR24 (Q96S15). Catalytic component of the GATOR2 complex, a multiprotein complex that acts as an activator of the amino acid-sensing branch of the mTORC1 signaling pathway. It is a selective cancer dependency (DepMap: 60.0% of cell lines).

Enables ubiquitin protein ligase activity. Involved in several processes, including cellular response to amino acid starvation; positive regulation of TORC1 signaling; and protein K6-linked ubiquitination. Located in cytosol and lysosomal membrane. Part of GATOR2 complex.

Source: NCBI Gene 84219 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 120 total
  • Cancer dependency (DepMap): dependent in 60.0% of screened cell lines
  • MANE Select transcript: NM_032259

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20852
Approved symbolWDR24
NameWD repeat domain 24
Location16p13.3
Locus typegene with protein product
StatusApproved
AliasesDKFZp434F054, JFP7
Ensembl geneENSG00000127580
Ensembl biotypeprotein_coding
OMIM620307
Entrez84219

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 6 protein_coding, 1 retained_intron

ENST00000248142, ENST00000293883, ENST00000567014, ENST00000647644, ENST00000886263, ENST00000886264, ENST00000933313

RefSeq mRNA: 1 — MANE Select: NM_032259 NM_032259

CCDS: CCDS10420

Canonical transcript exons

ENST00000293883 — 9 exons

ExonStartEnd
ENSE00000873928684992685176
ENSE00000873929685257685597
ENSE00000873931685869685990
ENSE00000873932686068686186
ENSE00000873933686744687416
ENSE00000873934687562687739
ENSE00001352797689160690398
ENSE00001529438684622684902
ENSE00003496887685679685783

Expression profiles

Bgee: expression breadth ubiquitous, 170 present calls, max score 85.20.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8991 / max 73.0948, expressed in 1784 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1557509.65081777
1557511.2482815

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130285.20gold quality
apex of heartUBERON:000209884.01gold quality
right hemisphere of cerebellumUBERON:001489083.13gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.88gold quality
gastrocnemiusUBERON:000138882.11gold quality
cerebellar hemisphereUBERON:000224581.83gold quality
stromal cell of endometriumCL:000225581.70gold quality
hindlimb stylopod muscleUBERON:000425281.61gold quality
cerebellar cortexUBERON:000212981.60gold quality
right adrenal glandUBERON:000123381.29gold quality
left testisUBERON:000453381.26gold quality
right testisUBERON:000453481.18gold quality
right frontal lobeUBERON:000281081.12gold quality
granulocyteCL:000009481.05gold quality
muscle of legUBERON:000138380.95gold quality
right lobe of thyroid glandUBERON:000111980.90gold quality
right adrenal gland cortexUBERON:003582780.82gold quality
left adrenal glandUBERON:000123480.57gold quality
right lobe of liverUBERON:000111480.46gold quality
left adrenal gland cortexUBERON:003582580.44gold quality
right ovaryUBERON:000211880.03gold quality
left ovaryUBERON:000211979.73gold quality
left lobe of thyroid glandUBERON:000112079.64gold quality
skin of legUBERON:000151179.63gold quality
adenohypophysisUBERON:000219679.58gold quality
mucosa of transverse colonUBERON:000499179.56gold quality
lower esophagus muscularis layerUBERON:003583379.54gold quality
lower esophagusUBERON:001347379.51gold quality
body of stomachUBERON:000116179.43gold quality
cerebellumUBERON:000203779.38gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.73

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

1 targeting WDR24, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-138-1-3P98.2567.89867

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 60.0% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • Consistent with our findings in Drosophila, through the characterization of a wdr24-/- knockout HeLa cell line we determined that Wdr24 promotes lysosome acidification and autophagic flux in mammalian cells (PMID:27166823)
  • The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation. (PMID:31915252)
  • CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth. (PMID:36995937)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriowdr24ENSDARG00000025507
mus_musculusWdr24ENSMUSG00000025737
rattus_norvegicusWdr24ENSRNOG00000019713
drosophila_melanogasterWdr24FBGN0027518

Paralogs (9): ERCC8 (ENSG00000049167), GEMIN5 (ENSG00000082516), RBBP7 (ENSG00000102054), WDR59 (ENSG00000103091), GRWD1 (ENSG00000105447), PEX7 (ENSG00000112357), WDR77 (ENSG00000116455), RBBP4 (ENSG00000162521), WDR73 (ENSG00000177082)

Protein

Protein identifiers

GATOR2 complex protein WDR24Q96S15 (reviewed: Q96S15)

Alternative names: WD repeat-containing protein 24

All UniProt accessions (3): Q96S15, A0A3B3ISA1, A0A499FJD3

UniProt curated annotations — full annotation on UniProt →

Function. Catalytic component of the GATOR2 complex, a multiprotein complex that acts as an activator of the amino acid-sensing branch of the mTORC1 signaling pathway. The GATOR2 complex indirectly activates mTORC1 through the inhibition of the GATOR1 subcomplex. GATOR2 probably acts as an E3 ubiquitin-protein ligase toward GATOR1. In the presence of abundant amino acids, the GATOR2 complex mediates ubiquitination of the NPRL2 core component of the GATOR1 complex, leading to GATOR1 inactivation. In the absence of amino acids, GATOR2 is inhibited, activating the GATOR1 complex. In addition to its role in regulation of the mTORC1 complex, promotes the acidification of lysosomes and facilitates autophagic flux. Within the GATOR2 complex, WDR24 constitutes the catalytic subunit that mediates ‘Lys-6’-linked ubiquitination of NPRL2.

Subunit / interactions. Component of the GATOR2 subcomplex, composed of MIOS, SEC13, SEH1L, WDR24 and WDR59. The GATOR2 complex interacts with CASTOR1 and CASTOR2; the interaction is negatively regulated by arginine. The GATOR2 complex interacts with SESN1, SESN2 and SESN3; the interaction is negatively regulated by amino acids. SESN1, SESN2 and SESN3 convey leucine availability via direct interaction with SEH1L and WDR24.

Subcellular location. Lysosome membrane.

Post-translational modifications. Phosphorylation at Ser-155 by AMPK in response to glucose deprivation inactivates WDR24 by promoting interaction with 14-3-3 proteins, such as YWHAG, preventing assembly of the GATOR2 complex. Autoubiquitinated; MIOS is required to prevent autoubiquitination.

Activity regulation. The GATOR2 complex is negatively regulated by the upstream amino acid sensors CASTOR1 and SESN2, which sequester the GATOR2 complex in absence of amino acids. In the presence of abundant amino acids, GATOR2 is released from CASTOR1 and SESN2 and activated.

Pathway. Protein modification; protein ubiquitination.

Similarity. Belongs to the WD repeat WDR24 family.

RefSeq proteins (1): NP_115635* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001680WD40_rptRepeat
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR019775WD40_repeat_CSConserved_site
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR037590WDR24Family

Pfam: PF00400

UniProt features (35 total): binding site 15, repeat 6, modified residue 6, mutagenesis site 5, zinc finger region 2, chain 1

Structure

Experimental structures (PDB)

5 structures.

PDBMethodResolution (Å)
9LWFELECTRON MICROSCOPY3.41
9OTIELECTRON MICROSCOPY3.5
9LVKELECTRON MICROSCOPY3.59
7UHYELECTRON MICROSCOPY3.66
9LVJELECTRON MICROSCOPY3.82

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96S15-F174.260.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (15): 722; 733; 736; 743; 746; 757; 760; 762; 765; 768; 779; 783

Post-translational modifications (6): 155, 470, 496, 581, 594, 598

Mutagenesis-validated functional residues (5):

PositionPhenotype
155abolished phosphorylation by ampk.
155mimics phosphorylation, leading to inhibit mtorc1 activation.
451abolished interaction with wdr59 and assembly of the gator2 complex; when associated with e-632-633-e.
632–633abolished interaction with wdr59 and assembly of the gator2 complex; when associated with e-451.
743–746impaired amino-acid-mediated mtorc1 activation.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9639288Amino acids regulate mTORC1

MSigDB gene sets: 119 (showing top): GOBP_REGULATION_OF_AUTOPHAGY, GOCC_VACUOLAR_MEMBRANE, GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING, GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY, GOBP_MACROAUTOPHAGY, GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, GOBP_CELLULAR_RESPONSE_TO_STARVATION, GOBP_TOR_SIGNALING, GOBP_LOCALIZATION_WITHIN_MEMBRANE

GO Biological Process (16): autophagy (GO:0006914), regulation of autophagy (GO:0010506), positive regulation of macroautophagy (GO:0016239), cellular response to nutrient levels (GO:0031669), positive regulation of TOR signaling (GO:0032008), cellular response to amino acid starvation (GO:0034198), protein localization to plasma membrane (GO:0072659), protein K6-linked ubiquitination (GO:0085020), negative regulation of TORC1 signaling (GO:1904262), positive regulation of TORC1 signaling (GO:1904263), cytoplasmic translation (GO:0002181), protein ubiquitination (GO:0016567), TORC1 signaling (GO:0038202), negative regulation of translational initiation (GO:0045947), positive regulation of translational initiation (GO:0045948), protein localization to lysosome (GO:0061462)

GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), transferase activity (GO:0016740), metal ion binding (GO:0046872)

GO Cellular Component (6): lysosomal membrane (GO:0005765), vacuolar membrane (GO:0005774), cytosol (GO:0005829), GATOR2 complex (GO:0061700), lysosome (GO:0005764), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Cellular response to starvation1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
TOR signaling2
TORC1 signaling2
regulation of TORC1 signaling2
translational initiation2
regulation of translational initiation2
cellular anatomical structure2
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
autophagy1
regulation of catabolic process1
positive regulation of autophagy1
macroautophagy1
regulation of macroautophagy1
response to nutrient levels1
cellular response to stimulus1
regulation of TOR signaling1
positive regulation of intracellular signal transduction1
cellular response to starvation1
response to amino acid starvation1
protein localization to membrane1
protein localization to cell periphery1
protein polyubiquitination1
negative regulation of TOR signaling1
positive regulation of TOR signaling1
translation1
protein modification by small protein conjugation1
negative regulation of translation1
positive regulation of translation1
protein localization to vacuole1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
catalytic activity1
cation binding1
lysosome1
lytic vacuole membrane1
vacuole1
bounding membrane of organelle1

Protein interactions and networks

STRING

1086 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
WDR24MIOSQ9NXC5998
WDR24SEC13P55735997
WDR24SEH1LQ96EE3997
WDR24WDR59Q6PJI9993
WDR24NPRL2Q8WTW4848
WDR24NPRL3Q12980847
WDR24DEPDC5O75140817
WDR24SESN2P58004767
WDR24RRAGBQ5VZM2759
WDR24RRAGCQ9HB90732
WDR24CASTOR2A6NHX0728
WDR24RRAGAQ7L523725
WDR24SESN1Q9Y6P5724
WDR24RRAGDQ9NQL2715
WDR24ITFG2Q969R8684

IntAct

83 interactions, top by confidence:

ABTypeScore
WDR24MIOSpsi-mi:“MI:0915”(physical association)0.940
MIOSWDR24psi-mi:“MI:0915”(physical association)0.940
WDR24SESN2psi-mi:“MI:0915”(physical association)0.890
WDR24SESN2psi-mi:“MI:0914”(association)0.890
SESN2WDR24psi-mi:“MI:0914”(association)0.890
SESN2WDR24psi-mi:“MI:0915”(physical association)0.890
NPRL2NPRL3psi-mi:“MI:0914”(association)0.850
NPRL2NPRL3psi-mi:“MI:0403”(colocalization)0.850
RBBP5KMT2Dpsi-mi:“MI:0914”(association)0.840
MIOSSEC13psi-mi:“MI:0914”(association)0.790
CASTOR1CASTOR1psi-mi:“MI:0914”(association)0.770
WDR24SEC13psi-mi:“MI:0914”(association)0.730
CASTOR1CASTOR2psi-mi:“MI:0914”(association)0.710

BioGRID (96): WDR24 (Two-hybrid), WDR24 (Affinity Capture-MS), WDR24 (Affinity Capture-MS), WDR24 (Two-hybrid), WDR24 (Affinity Capture-MS), WDR24 (Biochemical Activity), WDR24 (Affinity Capture-MS), WDR24 (Affinity Capture-MS), WDR24 (Affinity Capture-MS), MIOS (Affinity Capture-Western), WDR59 (Affinity Capture-Western), SEH1L (Affinity Capture-Western), SEC13 (Affinity Capture-Western), DEPDC5 (Affinity Capture-Western), NPRL3 (Affinity Capture-Western)

ESM2 similar proteins: A0A396ISC0, O00423, O13286, O17468, O61585, O94423, P26309, P38328, P43254, P53197, P78972, P93471, Q04199, Q05BC3, Q09373, Q12834, Q16MY0, Q2TAF3, Q32SG6, Q3E906, Q4PSE4, Q4V7Y7, Q4V8C3, Q54MZ3, Q5H7C0, Q5ZIU8, Q62623, Q652L2, Q6DIP5, Q6NVM2, Q6S7B0, Q7K0L4, Q7ZUV2, Q7ZVL2, Q7ZX22, Q86Y33, Q8BG40, Q8CFJ9, Q8L3Z8, Q8LPL5

Diamond homologs: A5E6M3, A6ZN74, A7TR10, B3LIS9, C5DJV1, C5DSV0, C7GV13, C8ZHH9, Q08281, Q5ZMV9, Q6CME1, Q6FVJ1, Q75AV6, Q7ZVL2, Q8CFJ9, Q96S15, Q7ZX22, Q9VKK2, A3GIA4, B9WN49, C4Y5P7, C4YN69, C5MIB1, Q5ACL4, Q6BXX5, A2AKB9, A7RHG8, B2AEZ5, B2B766, B4JPT9, B9WD30, C4YPI7, C5MJE8, O14021, O22466, O22467, O22468, O22469, O93377, O94244

SIGNOR signaling

1 interactions.

AEffectBMechanism
WDR24“form complex”GATOR2binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 47 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Amino acids regulate mTORC11161.2×3e-15
Cellular response to starvation732.2×2e-07
Cellular responses to stress1010.2×2e-06
Cellular responses to stimuli108.7×8e-06

GO biological processes:

GO termPartnersFoldFDR
negative regulation of TORC1 signaling1290.4×6e-19
cellular response to amino acid starvation1181.3×6e-17
positive regulation of TORC1 signaling641.2×5e-07
protein stabilization57.8×6e-03
intracellular protein transport57.5×6e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

120 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance107
Likely benign7
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1978 predictions. Top by Δscore:

VariantEffectΔscore
16:685019:ATGGG:Adonor_gain1.0000
16:685172:TGCTC:Tacceptor_gain1.0000
16:685174:CTC:Cacceptor_gain1.0000
16:685175:TC:Tacceptor_gain1.0000
16:685176:CC:Cacceptor_gain1.0000
16:685177:C:CCacceptor_gain1.0000
16:685177:CTGG:Cacceptor_loss1.0000
16:685178:T:Gacceptor_loss1.0000
16:685253:ACACC:Adonor_loss1.0000
16:685256:C:Tdonor_loss1.0000
16:685677:A:ACdonor_gain1.0000
16:685678:C:CCdonor_gain1.0000
16:685678:CG:Cdonor_gain1.0000
16:685678:CGGTG:Cdonor_gain1.0000
16:685780:TTAT:Tacceptor_gain1.0000
16:685781:TAT:Tacceptor_gain1.0000
16:685782:ATC:Aacceptor_loss1.0000
16:685783:TCT:Tacceptor_loss1.0000
16:685784:C:CAacceptor_loss1.0000
16:685784:C:CCacceptor_gain1.0000
16:685785:T:Aacceptor_loss1.0000
16:685789:C:Tacceptor_gain1.0000
16:685790:G:Tacceptor_gain1.0000
16:685867:AC:Adonor_gain1.0000
16:685868:CC:Cdonor_gain1.0000
16:685868:CCCT:Cdonor_gain1.0000
16:685986:TGAAA:Tacceptor_gain1.0000
16:685991:C:CCacceptor_gain1.0000
16:686739:CCTA:Cdonor_gain1.0000
16:684988:CCA:Cdonor_loss0.9900

AlphaMissense

5242 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:684880:A:GC743R1.000
16:684999:A:GC733R1.000
16:685039:G:CC719W1.000
16:685041:A:GC719R1.000
16:686174:A:GW449R1.000
16:686174:A:TW449R1.000
16:687119:C:AK319N1.000
16:687119:C:GK319N1.000
16:687161:C:AW305C1.000
16:687161:C:GW305C1.000
16:687162:C:GW305S1.000
16:687163:A:GW305R1.000
16:687163:A:TW305R1.000
16:687233:C:AW281C1.000
16:687233:C:GW281C1.000
16:687235:A:GW281R1.000
16:687235:A:TW281R1.000
16:687237:A:TV280D1.000
16:687270:G:TT269K1.000
16:687273:G:TA268D1.000
16:687274:C:GA268P1.000
16:687299:C:AW259C1.000
16:687299:C:GW259C1.000
16:687300:C:GW259S1.000
16:687301:A:GW259R1.000
16:687301:A:TW259R1.000
16:687321:G:TA252D1.000
16:687371:C:AW235C1.000
16:687371:C:GW235C1.000
16:687372:C:GW235S1.000

dbSNP variants (sampled 300 via entrez): RS1000709095 (16:688058 T>C,G), RS1001145224 (16:691073 T>C,G), RS1001194178 (16:684298 G>A,C), RS1001333493 (16:690549 G>T), RS1001429415 (16:688007 G>A,C,T), RS1001460664 (16:688325 C>A), RS1001783449 (16:691981 A>G), RS1002097573 (16:692159 G>A), RS1002479150 (16:687317 C>T), RS1002796321 (16:691193 C>T), RS1003067741 (16:691572 G>A,T), RS1003098762 (16:691384 G>A), RS1003650523 (16:684783 C>A,G,T), RS1003711995 (16:686517 A>G), RS1004445903 (16:691393 G>A,C,T)

Disease associations

OMIM: gene MIM:620307 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST008810_72Smoking initiation (ever regular vs never regular)5.000000e-09
GCST012227_279Hip circumference adjusted for BMI3.000000e-12
GCST90000047_259Age at first sexual intercourse5.000000e-11

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005670smoking initiation
EFO:0008039BMI-adjusted hip circumference
EFO:0009749age at first sexual intercourse measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB clinical annotations

1 annotations.

VariantTypeLevelDrugsPhenotypes
rs11640115Efficacy3aspirin;clopidogrelAcute coronary syndrome;Major Adverse Cardiac Events (MACE)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs11640115JMJD8, WDR2433.501aspirin;clopidogrel

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
sodium arsenitedecreases expression1
benzo(e)pyreneincreases methylation1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
abrineincreases expression1
Sunitinibincreases expression1
Fulvestrantincreases methylation1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyrenedecreases expression1
Caffeineaffects phosphorylation1
Methapyrileneincreases methylation1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Valproic Acidincreases methylation1
Vanadiumincreases abundance, increases methylation1
Metals, Heavyincreases abundance, increases methylation1
Lactic Aciddecreases expression1
Acrylamidedecreases expression1
Particulate Matterdecreases expression, increases abundance1

Cellosaurus cell lines

3 cell lines: 2 cancer cell line, 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D9VQUbigene HEK293 WDR24 KOTransformed cell lineFemale
CVCL_TX86HAP1 WDR24 (-) 1Cancer cell lineMale
CVCL_TX87HAP1 WDR24 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.